/Hologic%2C%20Inc_%20%20magnified%20-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
With a market cap of $18.3 billion, Hologic, Inc. (HOLX) specializes in developing and supplying diagnostics, medical imaging systems, and surgical products focused on women's health. Based in Marlborough, Massachusetts, the company is expected to unveil its fiscal Q3 earnings results after the market closes on Monday, Jul. 29.
Prior to the event, analysts anticipate HOLX to report a profit of $1.02 per share, up 9.7% from $0.93 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in each of the past four quarters. The company reported an EPS of $1.03 in the most recent quarter, exceeding the consensus EPS estimate by a 6.2% margin due to the non-covid segment’s solid growth.